Logo image of CHR.CA

CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:CHR - CA17040T8885 - Common Stock

21.56 CAD
-0.04 (-0.19%)
Last: 1/9/2026, 7:00:00 PM
Fundamental Rating

5

CHR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 6 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR get a neutral evaluation. Nothing too spectacular is happening here. CHR is cheap, but on the other hand it scores bad on growth. With these ratings, CHR could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CHR was profitable.
In the past year CHR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CHR reported negative net income in multiple years.
In the past 5 years CHR always reported a positive cash flow from operatings.
CHR.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

CHR has a Return On Assets of -2.62%. This is comparable to the rest of the industry: CHR outperforms 50.00% of its industry peers.
The Return On Equity of CHR (-6.31%) is better than 83.33% of its industry peers.
With an excellent Return On Invested Capital value of 6.40%, CHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CHR is in line with the industry average of 4.35%.
The last Return On Invested Capital (6.40%) for CHR is above the 3 year average (5.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROIC 6.4%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR.CA Yearly ROA, ROE, ROICCHR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

CHR has a better Operating Margin (6.81%) than 83.33% of its industry peers.
CHR's Operating Margin has declined in the last couple of years.
The Gross Margin of CHR (65.68%) is better than 100.00% of its industry peers.
CHR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.81%
PM (TTM) N/A
GM 65.68%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR.CA Yearly Profit, Operating, Gross MarginsCHR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHR is destroying value.
The number of shares outstanding for CHR has been reduced compared to 1 year ago.
CHR has more shares outstanding than it did 5 years ago.
CHR has a better debt/assets ratio than last year.
CHR.CA Yearly Shares OutstandingCHR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR.CA Yearly Total Debt VS Total AssetsCHR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CHR has an Altman-Z score of 0.90. This is a bad value and indicates that CHR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.90, CHR is in line with its industry, outperforming 50.00% of the companies in the same industry.
CHR has a debt to FCF ratio of 10.63. This is a negative value and a sign of low solvency as CHR would need 10.63 years to pay back of all of its debts.
The Debt to FCF ratio of CHR (10.63) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that CHR is somewhat dependend on debt financing.
The Debt to Equity ratio of CHR (0.50) is better than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Altman-Z 0.9
ROIC/WACC0.79
WACC8.11%
CHR.CA Yearly LT Debt VS Equity VS FCFCHR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

CHR has a Current Ratio of 1.22. This is a normal value and indicates that CHR is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CHR (1.22) is better than 66.67% of its industry peers.
A Quick Ratio of 0.63 indicates that CHR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.63, CHR is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 0.63
CHR.CA Yearly Current Assets VS Current LiabilitesCHR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 92.86% over the past year.
The earnings per share for CHR have been decreasing by -19.03% on average. This is quite bad
The Revenue has decreased by -8.40% in the past year.
Measured over the past years, CHR shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%

3.2 Future

CHR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.19% yearly.
The Revenue is expected to decrease by -4.52% on average over the next years.
EPS Next Y61.87%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue Next Year-6.45%
Revenue Next 2Y-5.27%
Revenue Next 3Y-4.52%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHR.CA Yearly Revenue VS EstimatesCHR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR.CA Yearly EPS VS EstimatesCHR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.87, the valuation of CHR can be described as very reasonable.
CHR's Price/Earnings ratio is rather cheap when compared to the industry. CHR is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of CHR to the average of the S&P500 Index (27.25), we can say CHR is valued rather cheaply.
The Price/Forward Earnings ratio is 10.97, which indicates a very decent valuation of CHR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CHR indicates a rather cheap valuation: CHR is cheaper than 83.33% of the companies listed in the same industry.
CHR is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.98, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.87
Fwd PE 10.97
CHR.CA Price Earnings VS Forward Price EarningsCHR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

83.33% of the companies in the same industry are more expensive than CHR, based on the Enterprise Value to EBITDA ratio.
66.67% of the companies in the same industry are more expensive than CHR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.54
EV/EBITDA 3.91
CHR.CA Per share dataCHR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

CHR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CHR has a very decent profitability rating, which may justify a higher PE ratio.
CHR's earnings are expected to grow with 14.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y14.11%
EPS Next 3Y14.19%

3

5. Dividend

5.1 Amount

CHR has a Yearly Dividend Yield of 1.48%.
Compared to an average industry Dividend Yield of 1.02, CHR pays a bit more dividend than its industry peers.
Compared to the average S&P500 Dividend Yield of 1.92, CHR is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.48%

5.2 History

On average, the dividend of CHR grows each year by 21.58%, which is quite nice.
CHR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
CHR.CA Yearly Dividends per shareCHR.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2025 1 2 3

5.3 Sustainability

The earnings of CHR are negative and hence is the payout ratio. CHR will probably not be able to sustain this dividend level.
The dividend of CHR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-5.89%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
CHR.CA Yearly Income VS Free CF VS DividendCHR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHORUS AVIATION INC

TSX:CHR (1/9/2026, 7:00:00 PM)

21.56

-0.04 (-0.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners3.74%
Inst Owner ChangeN/A
Ins Owners1.28%
Ins Owner ChangeN/A
Market Cap504.94M
Revenue(TTM)1.35B
Net Income(TTM)-34.96M
Analysts78.18
Price Target30.26 (40.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.48%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-5.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)3.86%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)11.06%
Min EPS beat(4)3.86%
Max EPS beat(4)25.51%
EPS beat(8)6
Avg EPS beat(8)17.12%
EPS beat(12)6
Avg EPS beat(12)4.64%
EPS beat(16)8
Avg EPS beat(16)3.17%
Revenue beat(2)0
Avg Revenue beat(2)-6.2%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-4.09%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)2
Avg Revenue beat(8)-4.05%
Revenue beat(12)5
Avg Revenue beat(12)-1.79%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)5.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.14%
EPS NY rev (1m)0%
EPS NY rev (3m)4.22%
Revenue NQ rev (1m)-2.01%
Revenue NQ rev (3m)-2.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.68%
Valuation
Industry RankSector Rank
PE 8.87
Fwd PE 10.97
P/S 0.37
P/FCF 15.54
P/OCF 7.09
P/B 0.91
P/tB 0.93
EV/EBITDA 3.91
EPS(TTM)2.43
EY11.27%
EPS(NY)1.97
Fwd EY9.12%
FCF(TTM)1.39
FCFY6.44%
OCF(TTM)3.04
OCFY14.1%
SpS57.62
BVpS23.67
TBVpS23.29
PEG (NY)0.14
PEG (5Y)N/A
Graham Number35.98
Profitability
Industry RankSector Rank
ROA -2.62%
ROE -6.31%
ROCE 8.63%
ROIC 6.4%
ROICexc 6.56%
ROICexgc 6.62%
OM 6.81%
PM (TTM) N/A
GM 65.68%
FCFM 2.41%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 10.63
Debt/EBITDA 1.32
Cap/Depr 32.58%
Cap/Sales 2.87%
Interest Coverage 2.74
Cash Conversion 33.79%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 0.63
Altman-Z 0.9
F-Score6
WACC8.11%
ROIC/WACC0.79
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
EPS Next Y61.87%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%
Revenue Next Year-6.45%
Revenue Next 2Y-5.27%
Revenue Next 3Y-4.52%
Revenue Next 5YN/A
EBIT growth 1Y-34.45%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year87.77%
EBIT Next 3Y14.37%
EBIT Next 5YN/A
FCF growth 1Y-89.3%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-80.17%
OCF growth 3Y12.73%
OCF growth 5Y0.25%

CHORUS AVIATION INC / CHR.CA FAQ

What is the fundamental rating for CHR stock?

ChartMill assigns a fundamental rating of 5 / 10 to CHR.CA.


Can you provide the valuation status for CHORUS AVIATION INC?

ChartMill assigns a valuation rating of 8 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Undervalued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR.CA) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CHR stock?

The Price/Earnings (PE) ratio for CHORUS AVIATION INC (CHR.CA) is 8.87 and the Price/Book (PB) ratio is 0.91.


How financially healthy is CHORUS AVIATION INC?

The financial health rating of CHORUS AVIATION INC (CHR.CA) is 5 / 10.